AD-04,ADvantage
- Generic Name
- AD-04,ADvantage
KLH Challenge to Explore the Human Immune Response
Not Applicable
Recruiting
- Conditions
- Immune Response
- Interventions
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 39
- Registration Number
- NCT05876195
- Locations
- 🇬🇧
NIHR Oxford Experimental Medicine Clinical Research Facility, Oxford, United Kingdom
Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults
Phase 1
Completed
- Conditions
- Malaria
- Interventions
- First Posted Date
- 2016-01-18
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Target Recruit Count
- 68
- Registration Number
- NCT02658253
- Locations
- 🇧🇫
CNRFP, Ouagadougou, Burkina Faso
🇫🇷CIC 1417, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath